Revenue - PYC Therapeutics Ltd (ASX:PYC) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.1 AUD 5.26%

Updated:

PYC Therapeutics Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

PYC Therapeutics Ltd
Revenue Peer Comparison

IMM

MSB

CSL

CUV

TLX

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	PYC Therapeutics Ltd ASX:PYC	Revenue AU$21.5m	CAGR 3-Years 99%	CAGR 5-Years 377%	CAGR 10-Years 32%
	Immutep Ltd ASX:IMM	Revenue AU$256.6k	CAGR 3-Years -61%	CAGR 5-Years -45%	CAGR 10-Years -24%
	Mesoblast Ltd ASX:MSB	Revenue $7.5m	CAGR 3-Years -23%	CAGR 5-Years -14%	CAGR 10-Years N/A
	CSL Ltd ASX:CSL	Revenue $14.2B	CAGR 3-Years 12%	CAGR 5-Years 11%	CAGR 10-Years 10%
	Clinuvel Pharmaceuticals Ltd ASX:CUV	Revenue AU$87.3m	CAGR 3-Years 31%	CAGR 5-Years 25%	CAGR 10-Years 42%
	Telix Pharmaceuticals Ltd ASX:TLX	Revenue AU$502.5m	CAGR 3-Years 359%	CAGR 5-Years 381%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Revenue amounts to 21.5m AUD.

Over the last year, the Revenue growth was 60%. The average annual Revenue growth rates for PYC Therapeutics Ltd have been 99% over the past three years , 377% over the past five years , and 32% over the past ten years .

Join more than 137,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.